NRXP
NRX Pharmaceuticals Inc
NASDAQ: NRXP · HEALTHCARE · BIOTECHNOLOGY
$2.98
+2.41% today
Updated 2026-04-30
Market cap
$100.19M
P/E ratio
—
P/S ratio
81.79x
EPS (TTM)
$-1.34
Dividend yield
—
52W range
$2 – $4
Volume
0.9M
NRX Pharmaceuticals Inc (NRXP) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-135807.00 | $-473187.00 | $-792731.00 | $-2.27M | $-37.70M | $-39.76M | $-21.66M | $-10.64M | $-14.11M |
| Capital expenditures | $0.00 | $0.00 | $1.00 | $2000.00 | $7000.00 | $10000.00 | $3000.00 | $0.00 | $0.00 |
| Depreciation | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | — | $933.00 | $730000.00 | $7.79M | $3.63M | $387000.00 | $486000.00 | $228000.00 |
| Free cash flow | $-135807.00 | $-473187.00 | $-792732.00 | $-2.27M | $-37.71M | $-39.77M | $-21.66M | $-10.64M | $-14.11M |
| Investing cash flow | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $460.00 | — | — | — | — | — |